Isodiur Hta (Torasemide)

Torasemide inhibits the Na⁺/K⁺/2Cl⁻ cotransporter in the thick ascending limb of the loop of Henle. This action reduces reabsorption of sodium, chloride and potassium, leading to increased urinary excretion of these ions together with water, producing a potent diuretic and antihypertensive effect.

The appropriate dose of Isodiur Hta is determined by the prescribing healthcare professional based on the patient’s specific condition, severity of fluid overload, renal function, and response to therapy. Dosage adjustments are individualized and should follow the prescriber’s instructions.

Safety data for torasemide during pregnancy and lactation are limited. It should only be used if the potential benefit justifies the potential risk to the fetus or infant. Healthcare providers should evaluate the risk‑benefit profile before prescribing to pregnant or nursing women.

To order Isodiur Hta, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials. The team will then respond with pricing, availability, shipping details and any required import documentation.

Torasemide is generally considered more potent on a milligram‑for‑milligram basis and has a longer duration of action than furosemide, allowing once‑daily dosing in many cases. Both act on the same Na⁺/K⁺/2Cl⁻ cotransporter, but torasemide may cause less variability in electrolyte loss and may be better tolerated in some patients.

Isodiur Hta should be stored at room temperature, below 25 °C. Keep the tablets in their original packaging, protect them from moisture and direct light, and store them out of reach of children.

Isodiur Hta is taken orally, usually with a glass of water. It can be taken with or without food, but consistent administration with respect to meals helps maintain stable absorption. Patients should follow the dosing schedule prescribed by their healthcare provider.

The most serious risks include severe dehydration, marked electrolyte disturbances (especially low potassium or sodium), and acute kidney injury. These complications can lead to hypotension, arrhythmias, or renal failure, and require prompt medical attention if symptoms arise.

Isodiur Hta should be avoided in patients with known hypersensitivity to torasemide or other sulfonamide‑derived drugs, in those with anuria, and in individuals with severe electrolyte imbalances that cannot be corrected. Caution is also advised for patients with severe renal impairment or uncontrolled gout.